GlaxoSmithKline ( (GB:GSK) ) has provided an update.
GSK has announced the purchase of 508,000 of its own ordinary shares, which will be held as treasury shares, as part of its ongoing buyback program. This move is part of a non-discretionary agreement with Citigroup Global Markets Limited, aiming to manage the company’s capital structure and return value to shareholders.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company that operates in the pharmaceutical industry, focusing on the development and manufacturing of medicines, vaccines, and consumer healthcare products.
YTD Price Performance: 17.05%
Average Trading Volume: 8,145,452
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £63.51B
For a thorough assessment of GSK stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com